D-Dimer
D-Dimer measures the presence of fibrin degradation products in the blood, indicating recent or ongoing blood clot formation and breakdown.
D-Dimer is a blood test marker for clotting and its breakdown.
Key facts at a glance
- Units
- μg/mL FEU
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche D-Dimer, Abbott D-Dimer, Siemens D-Dimer, BioMerieux D-Dimer
D-Dimer is a protein fragment produced when a blood clot dissolves in the body. It is often used to help diagnose conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC).
The test is particularly useful in emergency settings to rule out the presence of life-threatening blood clots. A negative result generally indicates that there is no significant clotting activity, while a positive result requires further investigation to determine the cause.
Levels of D-Dimer can also be elevated in other conditions such as pregnancy, liver disease, and after surgery or trauma. Therefore, while it is a valuable diagnostic tool, it is not specific to any single condition.
Frequently asked questions
What does a high D-Dimer level mean?
Can D-Dimer be used to diagnose deep vein thrombosis (DVT)?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy